Inconsistencies Between Antiparkinsonian Drugs and ICD-10 Codes in Inpatients: A TOLBIAC Project Case Study

Stud Health Technol Inform. 2016;228:364-8.


In France, data derived from hospital information systems are adequate to feed the prospective payment system. The consistency between drugs prescribed to patients and their indications could solve difficulties related to the identification of ICD-10 undercoded chronic diseases as the Parkinson Disease. Our goal was to highlight patients' stays mentioning administration of antiparkinsonian drugs and not coded for Parkinson's disease. Our approach was to parameterize tables of associations between ICD-10 codes and drug identifiers in the Web100T® application that collects medical information in our hospital and displays related inconsistencies for patients' stays. Based on acute care patients' stays of the second semester of 2015, we identified 246 patients corresponding to 253 stays, for which 33% of stays were not coded with the ICD-10 G20 code of the Parkinson's disease. The precision of our approach was 29%. Based on these data we predict roughly 84 patient stays without mention of Parkinson Disease. We plan to extend this study to other drugs and other kinds of data available in the health information system, such as biology or medical devices in order to improve the coding of chronic diseases in our hospital.

MeSH terms

  • Antiparkinson Agents / therapeutic use*
  • Clinical Coding / standards*
  • Electronic Health Records
  • France
  • Humans
  • Inpatients*
  • International Classification of Diseases*
  • Parkinson Disease / drug therapy
  • Prospective Payment System


  • Antiparkinson Agents